A Clinical Study to Assess the Efficacy and Safety of Leriglitazone in Adult Male Subjects With Cerebral Adrenoleukodystrophy
Clinical trial NCT05819866 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05819866
- Sponsor
- Minoryx Therapeutics, S.L.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-12
- Primary completion
- 2027-05-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.